Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fish slime crock of gold at end of rainbow

07.09.2004


The slippery mucus on the skin of rainbow trout is being studied by scientists as a possible source of new medicines to fight infectious diseases, according to research presented Monday, 06 September 2004 at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

“Anglers, cooks and anyone cleaning up mess in their kitchen know how difficult it is to hold onto fresh slippery fish like rainbow trout,” says Dr Vyv Salisbury from the University of the West of England in Bristol. “Trout are tricky to grasp because of the thick mucus they secrete from their skin. This slime helps them in many ways, and contains important chemicals which let them fight off bacteria living in the river.”

The scientists are looking at the possibility that the same chemicals might be used to help people fight off infectious disease-causing bacteria including food poisoning culprits E. coli O157and Salmonella, and Pseudomonas aeruginosa which affects the lungs of vulnerable cystic fibrosis patients. To see if the fish slime has an effect, the team at UWE are using genetically modified disease-causing bacteria, which glow in the dark when they are active and stop glowing when they are killed. The drop in the light given off by these bioluminescent reporter bacteria when they are put on the fish slime is a very effective way of seeing how successful the slime action is, but it does mean that the researchers have to spend hours in a totally darkened lab, peering at the fish.



Extracts from the trout mucus have already been shown to prevent growth and slow down the metabolic activity of some of these types of infectious bacteria. “If we can purify and produce these chemicals commercially, they may give us a new type of antibiotic, badly needed with the growing menace of antibiotic-resistant bacteria,” says Dr Salisbury.

Faye Jones | alfa
Further information:
http://www.sgm.ac.uk

More articles from Life Sciences:

nachricht New Technique Maps Elusive Chemical Markers on Proteins
03.07.2015 | Salk Institute for Biological Studies

nachricht New approach to targeted cancer therapy
03.07.2015 | CECAD - Cluster of Excellence at the University of Cologne

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>